Uzbekistan has significantly increased the output of medicines and other pharmaceutical products. According to statistical data, during the period from January to July 2026, the country's enterprises produced essential pharmaceutical preparations worth 3.5 trillion soms. This figure exceeds the volume recorded for the same period last year by 20.7%.
According to the National Committee on Statistics, the majority of the country's pharmaceutical production over seven months was concentrated in Tashkent. The capital produced goods worth 2.1 trillion soms. Additionally, Syrdarya region produced 529 billion soms worth of products, while Tashkent region produced 286.4 billion soms.
Other regions also made a significant contribution to the total production. In Namangan region, the volume amounted to 214.2 billion soms, and in Samarkand region, it was 143.1 billion soms. Andijan region produced 83.6 billion soms, and Fergana region produced 63.5 billion soms.
The production volume in Surkhandarya region reached 53.7 billion soms, while in Khorezm region it was 20.6 billion soms. Kashkadarya region produced 17.4 billion soms, and Bukhara region produced 9.4 billion soms. The smallest volumes were recorded in Navoi and Jizzakh regions, at 0.2 and 0.1 billion soms, respectively.
Previously, in the second quarter of 2026, the Committee for Competition Development and Consumer Rights Protection discovered numerous cases of unjustified price increases for medicines. As a result of the inspection, consumers were compensated for damages amounting to 1.9 billion soms.
